Comparison 6. Tasosartan vs Placebo.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Change in trough SBP	3		Mean Difference (IV, Fixed, 95% CI)	Subtotals only
1.1 10 mg	1	85	Mean Difference (IV, Fixed, 95% CI)	‐2.70 [‐9.12, 3.72]
1.2 25 mg	1	142	Mean Difference (IV, Fixed, 95% CI)	‐5.4 [‐9.68, ‐1.12]
1.3 30 mg	1	83	Mean Difference (IV, Fixed, 95% CI)	‐5.70 [‐11.78, 0.38]
1.4 50 mg	1	262	Mean Difference (IV, Fixed, 95% CI)	‐8.40 [‐11.89, ‐4.91]
2 Change in trough DBP	3		Mean Difference (IV, Fixed, 95% CI)	Subtotals only
2.1 10 mg	1	85	Mean Difference (IV, Fixed, 95% CI)	‐1.50 [‐5.62, 2.62]
2.2 25 mg	1	142	Mean Difference (IV, Fixed, 95% CI)	‐3.1 [‐5.63, ‐0.57]
2.3 30 mg	1	83	Mean Difference (IV, Fixed, 95% CI)	‐3.7 [‐7.47, 0.07]
2.4 50 mg	1	262	Mean Difference (IV, Fixed, 95% CI)	‐2.00 [‐5.59, ‐2.41]